PYRIDINE AND PYRAZINE DERIVATIVES AS PREFERENTIAL CANNABINOID 2 AGONISTS

The invention relates to a compound of formula (I), wherein A1, A2 and R1-R5 are as defined in the description and in the claims. The compound of formula (I) can be used as cannabinoid 2 preferential agonist. L'invention concerne un composé de formule (I), dans laquelle A1, A2 et R1-R5 ont la s...

Full description

Saved in:
Bibliographic Details
Main Authors AMETAMEY, Simon M, ATZ, Kenneth, GRETHER, Uwe, GUBA, Wolfgang, GOBBI, Luca, KRETZ, Julian
Format Patent
LanguageEnglish
French
Published 02.01.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a compound of formula (I), wherein A1, A2 and R1-R5 are as defined in the description and in the claims. The compound of formula (I) can be used as cannabinoid 2 preferential agonist. L'invention concerne un composé de formule (I), dans laquelle A1, A2 et R1-R5 ont la signification indiquée dans la description et les revendications. Le composé de formule (I) peut être utilisé en tant qu'agoniste préférentiel de cannabinoïde 2.
Bibliography:Application Number: WO2019EP66733